- call +1-201-465-4211
- email sales@mrinsights.biz
Diabetes mellitus is a kind of chronic comprehensive disease mainly caused by glucose metabolism disorder due to absolute or relative deficiency of insulin or decreased insulin sensitivity of target cells. The occurrence of type 2 diabetes mellitus is a combination of peripheral insulin resistance and β cell dysfunction. the result of. When diabetes patients undergo diet and exercise therapy and diabetes care education, blood glucose control can still not reach the treatment goals, the need for drug treatment-Antidiabetic Drug
Scope of the Report:
This report focuses on the Antidiabetic Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The global anti-diabetic drug market is expected to witness significant growth during the forecast period. This growth is attributed due to increasing prevalence of diabetes and rising demand for oral anti-diabetic drugs. In addition, sedentary lifestyle, increasing the percentage of obesity, high-stress levels are considered as a major driving factor for the growth of oral anti-diabetic drugs market. Furthermore, technological advancement and medical reimbursements can also help in fuelling the growth of oral antidiabetic drug market. However, the high cost of drugs is considered as a major restraint for the market. Nonetheless ongoing research and huge market potential can bring growth opportunities for anti-diabetic market within the forecast period.
Based on the class of drug, the global anti-diabetic drug market is segmented into five types: sulfonylureas, meglitinides, biguanides, alpha-glucosidase inhibitors and others. Sulphonylureas segment of oral anti-diabetic drugs market accounted for the largest market share in 2018followed by biguanides derivatives. Sulfonylureas were the largest segment and acquired around 37% of world market share followed by biguanide derivatives in 2018 Sulfonylureas are a class of organic compounds used in medicine and agriculture. They are antidiabetic drugs widely used in the management of type 2 diabetes mellitus. They act by increasing insulin release from the beta cells in the pancreas.
The worldwide market for Antidiabetic Drug is expected to grow at a CAGR of roughly 9.0% over the next five years, will reach 76300 million US$ in 2023, from 49600 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Sanofi-Aventis
Eli Lilly
Oramed
Takeda
Boehringer Ingelheim
Novo Nordisk
Halozyme Therapeutics
Bristol-Myers Squibb
Pfizer
Tonghua Dongbao
Biocon
Wockhardt
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Alpha-Glucosidase Inhibitors
Biguanides, Sulphonylureas
Glp-1 Agonist
Meglitinides
Dpp-4 Inhibitors
Sglt–2
Thiazolodinediones
Market Segment by Applications, can be divided into
Type I Diabetes
Type II Diabetes
There are 15 Chapters to deeply display the global Antidiabetic Drug market.
Chapter 1, to describe Antidiabetic Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Antidiabetic Drug, with sales, revenue, and price of Antidiabetic Drug, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Antidiabetic Drug, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Antidiabetic Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Antidiabetic Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Antidiabetic Drug Introduction
1.2 Market Analysis by Type
1.2.1 Alpha-Glucosidase Inhibitors
1.2.2 Biguanides, Sulphonylureas
1.2.3 Glp-1 Agonist
1.2.4 Meglitinides
1.2.5 Dpp-4 Inhibitors
1.2.6 Sglt–2
1.2.7 Thiazolodinediones
1.3 Market Analysis by Applications
1.3.1 Type I Diabetes
1.3.2 Type II Diabetes
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi-Aventis
2.1.1 Business Overview
2.1.2 Antidiabetic Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Sanofi-Aventis Antidiabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Eli Lilly
2.2.1 Business Overview
2.2.2 Antidiabetic Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Eli Lilly Antidiabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Oramed
2.3.1 Business Overview
2.3.2 Antidiabetic Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Oramed Antidiabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Takeda
2.4.1 Business Overview
2.4.2 Antidiabetic Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Takeda Antidiabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Boehringer Ingelheim
2.5.1 Business Overview
2.5.2 Antidiabetic Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Boehringer Ingelheim Antidiabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Novo Nordisk
2.6.1 Business Overview
2.6.2 Antidiabetic Drug Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Novo Nordisk Antidiabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Halozyme Therapeutics
2.7.1 Business Overview
2.7.2 Antidiabetic Drug Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Halozyme Therapeutics Antidiabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Bristol-Myers Squibb
2.8.1 Business Overview
2.8.2 Antidiabetic Drug Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Bristol-Myers Squibb Antidiabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Pfizer
2.9.1 Business Overview
2.9.2 Antidiabetic Drug Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Pfizer Antidiabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Tonghua Dongbao
2.10.1 Business Overview
2.10.2 Antidiabetic Drug Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Tonghua Dongbao Antidiabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Biocon
2.11.1 Business Overview
2.11.2 Antidiabetic Drug Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Biocon Antidiabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Wockhardt
2.12.1 Business Overview
2.12.2 Antidiabetic Drug Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Wockhardt Antidiabetic Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Antidiabetic Drug Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Antidiabetic Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Antidiabetic Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Antidiabetic Drug Manufacturer Market Share in 2017
3.3.2 Top 6 Antidiabetic Drug Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Antidiabetic Drug Market Analysis by Regions
4.1 Global Antidiabetic Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Antidiabetic Drug Sales and Market Share by Regions (2013-2018)
4.1.2 Global Antidiabetic Drug Revenue and Market Share by Regions (2013-2018)
4.2 North America Antidiabetic Drug Sales and Growth Rate (2013-2018)
4.3 Europe Antidiabetic Drug Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Antidiabetic Drug Sales and Growth Rate (2013-2018)
4.5 South America Antidiabetic Drug Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Antidiabetic Drug Sales and Growth Rate (2013-2018)
5 North America Antidiabetic Drug by Countries
5.1 North America Antidiabetic Drug Sales, Revenue and Market Share by Countries
5.1.1 North America Antidiabetic Drug Sales and Market Share by Countries (2013-2018)
5.1.2 North America Antidiabetic Drug Revenue and Market Share by Countries (2013-2018)
5.2 United States Antidiabetic Drug Sales and Growth Rate (2013-2018)
5.3 Canada Antidiabetic Drug Sales and Growth Rate (2013-2018)
5.4 Mexico Antidiabetic Drug Sales and Growth Rate (2013-2018)
6 Europe Antidiabetic Drug by Countries
6.1 Europe Antidiabetic Drug Sales, Revenue and Market Share by Countries
6.1.1 Europe Antidiabetic Drug Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Antidiabetic Drug Revenue and Market Share by Countries (2013-2018)
6.2 Germany Antidiabetic Drug Sales and Growth Rate (2013-2018)
6.3 UK Antidiabetic Drug Sales and Growth Rate (2013-2018)
6.4 France Antidiabetic Drug Sales and Growth Rate (2013-2018)
6.5 Russia Antidiabetic Drug Sales and Growth Rate (2013-2018)
6.6 Italy Antidiabetic Drug Sales and Growth Rate (2013-2018)
7 Asia-Pacific Antidiabetic Drug by Countries
7.1 Asia-Pacific Antidiabetic Drug Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Antidiabetic Drug Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Antidiabetic Drug Revenue and Market Share by Countries (2013-2018)
7.2 China Antidiabetic Drug Sales and Growth Rate (2013-2018)
7.3 Japan Antidiabetic Drug Sales and Growth Rate (2013-2018)
7.4 Korea Antidiabetic Drug Sales and Growth Rate (2013-2018)
7.5 India Antidiabetic Drug Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Antidiabetic Drug Sales and Growth Rate (2013-2018)
8 South America Antidiabetic Drug by Countries
8.1 South America Antidiabetic Drug Sales, Revenue and Market Share by Countries
8.1.1 South America Antidiabetic Drug Sales and Market Share by Countries (2013-2018)
8.1.2 South America Antidiabetic Drug Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Antidiabetic Drug Sales and Growth Rate (2013-2018)
8.3 Argentina Antidiabetic Drug Sales and Growth Rate (2013-2018)
8.4 Colombia Antidiabetic Drug Sales and Growth Rate (2013-2018)
9 Middle East and Africa Antidiabetic Drug by Countries
9.1 Middle East and Africa Antidiabetic Drug Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Antidiabetic Drug Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Antidiabetic Drug Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Antidiabetic Drug Sales and Growth Rate (2013-2018)
9.3 UAE Antidiabetic Drug Sales and Growth Rate (2013-2018)
9.4 Egypt Antidiabetic Drug Sales and Growth Rate (2013-2018)
9.5 Nigeria Antidiabetic Drug Sales and Growth Rate (2013-2018)
9.6 South Africa Antidiabetic Drug Sales and Growth Rate (2013-2018)
10 Global Antidiabetic Drug Market Segment by Type
10.1 Global Antidiabetic Drug Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Antidiabetic Drug Sales and Market Share by Type (2013-2018)
10.1.2 Global Antidiabetic Drug Revenue and Market Share by Type (2013-2018)
10.2 Alpha-Glucosidase Inhibitors Sales Growth and Price
10.2.1 Global Alpha-Glucosidase Inhibitors Sales Growth (2013-2018)
10.2.2 Global Alpha-Glucosidase Inhibitors Price (2013-2018)
10.3 Biguanides, Sulphonylureas Sales Growth and Price
10.3.1 Global Biguanides, Sulphonylureas Sales Growth (2013-2018)
10.3.2 Global Biguanides, Sulphonylureas Price (2013-2018)
10.4 Glp-1 Agonist Sales Growth and Price
10.4.1 Global Glp-1 Agonist Sales Growth (2013-2018)
10.4.2 Global Glp-1 Agonist Price (2013-2018)
10.5 Meglitinides Sales Growth and Price
10.5.1 Global Meglitinides Sales Growth (2013-2018)
10.5.2 Global Meglitinides Price (2013-2018)
10.6 Dpp-4 Inhibitors Sales Growth and Price
10.6.1 Global Dpp-4 Inhibitors Sales Growth (2013-2018)
10.6.2 Global Dpp-4 Inhibitors Price (2013-2018)
10.7 Sglt–2 Sales Growth and Price
10.7.1 Global Sglt–2 Sales Growth (2013-2018)
10.7.2 Global Sglt–2 Price (2013-2018)
10.8 Thiazolodinediones Sales Growth and Price
10.8.1 Global Thiazolodinediones Sales Growth (2013-2018)
10.8.2 Global Thiazolodinediones Price (2013-2018)
11 Global Antidiabetic Drug Market Segment by Application
11.1 Global Antidiabetic Drug Sales Market Share by Application (2013-2018)
11.2 Type I Diabetes Sales Growth (2013-2018)
11.3 Type II Diabetes Sales Growth (2013-2018)
12 Antidiabetic Drug Market Forecast (2018-2023)
12.1 Global Antidiabetic Drug Sales, Revenue and Growth Rate (2018-2023)
12.2 Antidiabetic Drug Market Forecast by Regions (2018-2023)
12.2.1 North America Antidiabetic Drug Market Forecast (2018-2023)
12.2.2 Europe Antidiabetic Drug Market Forecast (2018-2023)
12.2.3 Asia-Pacific Antidiabetic Drug Market Forecast (2018-2023)
12.2.4 South America Antidiabetic Drug Market Forecast (2018-2023)
12.2.5 Middle East and Africa Antidiabetic Drug Market Forecast (2018-2023)
12.3 Antidiabetic Drug Market Forecast by Type (2018-2023)
12.3.1 Global Antidiabetic Drug Sales Forecast by Type (2018-2023)
12.3.2 Global Antidiabetic Drug Market Share Forecast by Type (2018-2023)
12.4 Antidiabetic Drug Market Forecast by Application (2018-2023)
12.4.1 Global Antidiabetic Drug Sales Forecast by Application (2018-2023)
12.4.2 Global Antidiabetic Drug Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Antidiabetic Drug Picture
Table Product Specifications of Antidiabetic Drug
Figure Global Sales Market Share of Antidiabetic Drug by Types in 2017
Table
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
